|
Home | Your Profile | Search | About Us | Pricing | Disclaimer |
|
|
| |
Home | |
|
Outsourcing Reports | |
|
Outsourcing Showcase | |
|
Reports Store | |
|
Outsourcing Directory | |
|
Events | |
|
Advertising | |
|
News | |
| | Help |
11 Items, CDN $ 9895 |
Go Back ![]() |
|||
Abstract Following Amgen’s $16 billion acquisition of Immunex, Millennium’s $2 billion purchase of Cor Therapeutics and Medimmune's $1 billion acquisition of Aviron, the biotechnology industry has entered an era of consolidation and change. Increasing market pressures to generate profitable business models with long-term growth prospects demand robust, well diversified and highly competitive pipelines with clear therapeutic foci. This brief analyzes late phase pipelines of the 18 leading biotech companies over the next four years, forecasting how the revenue generated by the current pipelines will grow across six therapeutic areas and answering key questions such as: Which pipeline products and/or companies will lead revenue growth in 2006? and which technologies and therapies will dominate the market? Table of Contents Introduction Key biotech drivers: products Key biotech drivers: companies Key biotech drivers: therapy areas and technologies Oncology pipeline forecasts Potential oncology launches after 2006 Oncology pipeline revenue growth by company in 2006 Oncology pipeline revenue growth by technology in 2006 Inflammation and immune disorders (IDI) pipeline forecasts Potential IDI launches after 2006 IDI pipeline revenue growth by company, 2006 IDI pipeline revenue growth by technology, 2006 Anti-infectives pipeline forecasts Potential anti-infectives launches after 2006 IDI pipeline revenue growth by company, 2006 IDI pipeline revenue growth by R&D technology, 2006 CNS and cardiovascular pipeline forecasts Potential CNS and cardiovascular product launches after 2006 CNS and cardiovascular pipeline revenue growth by company, 2006 Cardiovascular pipeline revenue growth by technology, 2006 Niche areas pipeline forecasts Potential product launches in niche areas after 2006 Niche areas pipeline revenue growth by company, 2006 Niche areas pipeline revenue growth by technology, 2006 Datamonitor’s Competitive Intelligence Business Unit | |||
Using the Site Privacy & Security Statement
Advertise with us Directory Guide
CanBiotech Newsletters
© 2000-2010 CanBiotech™ Inc.